Skip to main content
Log in

Effektivität der antidepressiven Therapie bei Patienten mit mäßig ausgeprägter depressiver Symptomatik

Efficiency of antidepressant therapy for patients with less severe depression

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Bauer M, Whybrow PC, Angst J et al; World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5–43

    Article  PubMed  Google Scholar 

  2. Damm J, Eser D, Schule C et al (2009) Wirksamkeit antidepressiver Therapieverfahren auf depressive Kernsymptome. Nervenarzt 80:515–520

    Article  PubMed  CAS  Google Scholar 

  3. DeRubeis RJ, Fournier JC, Fawcett J (2010) Depression severity and effect of antidepressant medications – author reply. JAMA 303:1599

    Article  CAS  Google Scholar 

  4. Elkin I (2010) Depression severity and effect of antidepressant medications. JAMA 303:1596–1597

    Article  PubMed  CAS  Google Scholar 

  5. Finkelstein MM (2010) Depression severity and effect of antidepressant medications. JAMA 303:1596–1597

    Article  PubMed  CAS  Google Scholar 

  6. Möller HJ (2008) Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 258:451–455

    Article  PubMed  Google Scholar 

  7. Montgomery SA, Möller HJ (2009) Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? Int Clin Psychopharmacol 24:111–118

    Article  PubMed  Google Scholar 

  8. Sartorius N, Baghai TC, Baldwin DS et al (2007) Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 10 (Suppl 1):S1–S207

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

T.C. Baghai war als Referent für die Firmen Astra-Zeneca, Essex, Glaxo-Smith-Kline, Servier und Wyeth tätig.

H.J. Möller war als Referent oder Berater für die folgenden Firmen tätig: AstraZeneca, Bristol-Myers Squibb, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck, Merck, Novartis, Organon, Pfizer, Sanofi-Aventis, Schering-Plough, Schwabe, Sepracor, Servier und Wyeth.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T.C. Baghai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baghai, T., Möller, H. & Nitschmann, S. Effektivität der antidepressiven Therapie bei Patienten mit mäßig ausgeprägter depressiver Symptomatik. Internist 51, 1456–1458 (2010). https://doi.org/10.1007/s00108-010-2747-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-010-2747-6

Navigation